Diagnosing Dengue: Evaluating the Utility of Oral Fluid for Dengue Diagnosis
NCT02435615 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2017-10-26
Summary
Dengue is the most common viral illness spread by mosquitos. It is important to diagnose dengue to prompt adequate therapy and initiate local mosquito control. Easy to use point of care tests are needed to improve dengue diagnosis. Oral fluid collection may be a simple, non-invasive way to diagnose dengue in the community. However, it is currently unknown if oral fluid is an accurate way to diagnose dengue and if the use of a specialized oral fluid collector could help to improve dengue diagnosis. In this study, the investigators will analyze the oral fluid of suspected dengue patients compared to serum samples for dengue diagnosis. From this information the investigators will be able to determine if oral fluid is a convenient way to diagnose dengue and if the oral fluid collector aids in improving diagnosis.
Conditions
- Dengue
Interventions
- DEVICE
-
SaniSal Oral Fluid Collector
SaniSal is an oral fluid collector used to collect oral fluid from the mouth with an absorbant sponge.
Sponsors & Collaborators
-
Instituto Nacional de la Diabetes
collaborator UNKNOWN -
Hospital Infantil Dr. Robert Reid Cabral
collaborator OTHER -
University of Miami
lead OTHER
Principal Investigators
-
Justin Stoler, PhD MPH · University of Miami
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 2 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-31
- Primary Completion
- 2016-12-31
- Completion
- 2016-12-31
Countries
- Dominican Republic
Study Locations
More Related Trials
-
Study of AT-752 in Patients With Dengue Infection
NCT05466240 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever
NCT06006559 ·Status: RECRUITING ·Phase: PHASE2
-
An Evaluation of Repeated Oral Doses of JNJ-64281802 Against DENV-3 Challenge
NCT05048875 ·Status: COMPLETED ·Phase: PHASE2
-
Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC Test
NCT04782336 ·Status: SUSPENDED ·Phase: NA
-
A Study of JNJ-64281802 in Participants With Confirmed Dengue Fever
NCT04906980 ·Status: TERMINATED ·Phase: PHASE2
-
Viral Shedding, Symptoms and Exposure of SARS-CoV-2 in Non-hospitalized Children With COVID-19
NCT04666207 ·Status: COMPLETED
-
Rapid Flu Tests in Travelers With Fever
NCT00821626 ·Status: COMPLETED ·Phase: NA
-
Convalescent Plasma Treatment in Severe 2009 H1N1 Infection
NCT01306773 ·Status: COMPLETED ·Phase: NA
-
A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection
NCT04392232 ·Status: COMPLETED ·Phase: PHASE2
-
COVID-19 Molecular OTC At Home Test
NCT05704803 ·Status: COMPLETED ·Phase: NA
-
Anakinra in Dengue With Hyperinflammation ( AnaDen )
NCT05611710 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Controlled Human Rhinovirus Infection Study of 2-Deoxy-D-Glucose in Healthy Adults
NCT06375772 ·Status: TERMINATED ·Phase: PHASE2
-
Convalescent Plasma Therapy - Zurich Protocol
NCT04869072 ·Status: COMPLETED ·Phase: PHASE1
-
Convalescent Plasma in Pediatric COVID-19
NCT04458363 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study to Evaluate the Safety and Efficacy of AV-1 Against Dengue Virus 3 (DENV-3) Infection
NCT06799741 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Rapid Flu Testing in BMC ED
NCT02979730 ·Status: COMPLETED ·Phase: NA
-
A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza
NCT01231620 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Safety and Efficacy of ZX-7101A in Adolescents With Influenza
NCT06099873 ·Status: COMPLETED ·Phase: PHASE3
-
COVID-19: Human Epidemiology and Response to SARS-CoV-2
NCT04375761 ·Status: COMPLETED
-
Study of ZSP1273 in Patients With Acute Uncomplicated Influenza A
NCT04024137 ·Status: COMPLETED ·Phase: PHASE2
-
Development and Validation of "Ready-to-Use" Inhalable Forms of Hydroxychloroquine for Treatment of COVID-19
NCT04477083 ·Status: UNKNOWN ·Phase: NA
-
Study to Assess the Safety and Efficacy of ZX-7101A in Children Aged 5-11 Years With Influenza
NCT06669351 ·Status: TERMINATED ·Phase: PHASE3
-
Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19)
NCT04377672 ·Status: COMPLETED ·Phase: PHASE1
-
The Comparative Efficacy of Standard Treatment Plus Ribavirin vs Standard Treatment Alone in Preventing Clinically Significant Hemorrhage in Patients With Dengue Fever
NCT06744777 ·Status: COMPLETED ·Phase: PHASE3
-
Epidemiologic Assessment of SARS-CoV-2 (COVID-19) Prevalence in Minnesota
NCT04473183 ·Status: WITHDRAWN